雜志介紹

Diabetes Obesity & Metabolism雜志介紹

《Diabetes Obesity & Metabolism》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱糖尿病肥胖與代謝，本刊主要出版、報(bào)道醫(yī)學(xué)-ENDOCRINOLOGY & METABOLISM領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為5.4，最新CiteScore 指數(shù)為10.9。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies

  Author: Chen, Lihong; Sun, Shiyi; Gao, Yunyi; Ran, Xingwu

• Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register

  Author: Lim, Lee-Ling; Lau, Eric S. H.; Cheung, Johnny T. K.; Chan, Siew Pheng; Ji, Linong; Lim, Soo; Sirinvaravong, Sirinart; Unnikrishnan, A. G.; Luk, Andrea O. Y.; Cortese, Viviana; Durocher, Alexandra; Chan, Juliana C. N.

• Mendelian randomization identifies age at menarche as an independent causal effect factor for gestational diabetes mellitus

  Author: Lu, Likui; Wan, Bangbei; Sun, Miao

• Saxagliptin combined with additional oral antihyperglycaemic agents in drug-naive diabetic patients with high glycosylated haemoglobin: A 24-week, multicentre, randomized, open-label, active parallel-controlled group clinical trial in China (SUCCESS)

  Author: Chen, Xiaoping; Jiang, Hongwei; Li, Hongmei; Kuang, Hongyu; Chen, Li; Ma, Jianhua; Zhang, Qiu; Pan, Tianrong; Yang, Wenying

英文介紹

Diabetes Obesity & Metabolism雜志英文介紹

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.